中国神经再生研究(英文版) ›› 2023, Vol. 18 ›› Issue (11): 2436-2442.doi: 10.4103/1673-5374.371368

• 原著:脑损伤修复保护与再生 • 上一篇    下一篇

沉默Vav1可减轻脑缺血再灌注后的炎症反应和神经元凋亡

  

  • 出版日期:2023-11-15 发布日期:2023-05-04
  • 基金资助:
    辽宁省自然科学基金(一般项目)(2017010825)

Vav1 promotes inflammation and neuronal apoptosis in cerebral ischemia/reperfusion injury by upregulating microglial and NLRP3 inflammasome activation

Jing Qiu1, #, Jun Guo2, #, Liang Liu1, Xin Liu1, Xianhui Sun1, Huisheng Chen1, *   

  1. 1Department of Neurology, General Hospital of Northern Theater Command, Shenyang, Liaoning Province, China; 2Department of Neurology, Tangdu Hospital, Air Force Medical University, Xi’an, Shaanxi Province, China
  • Online:2023-11-15 Published:2023-05-04
  • Contact: Huisheng Chen, PhD, chszh@aliyun.com.
  • Supported by:
    This study was supported by the Natural Science Foundation of Liaoning Province (General Program), No. 2017010825 (to JQ).

摘要:

小胶质细胞作为中枢神经系统的巨噬细胞在脑缺血炎症反应中有重要意义,且鸟嘌呤核苷酸转换因子Vav1与小胶质细胞的激活有关,但Vav1具体如何参与脑缺血再灌注损伤后炎症反应尚不明确。实验以大脑中动脉闭塞再灌注大鼠和氧糖剥夺复氧诱导的BV-2小胶质细胞分别在体内外模拟脑缺血再灌注损伤,可见Vav1在大脑中动脉闭塞再灌注大鼠脑组织和氧糖剥夺复氧的BV-2细胞中均显著上调。而沉默Vav1可减少大脑中动脉闭塞再灌注大鼠的脑梗死体积和含水量,抑制缺血半暗带中神经元丢失和凋亡,改善神经功能。进一步分析发现Vav1主要存在于小胶质细胞,且Vav1下调可抑制缺血半暗带中小胶质细胞和NLRP3炎症小体的激活,抑制炎症因子的表达。同样敲低Vav1可抑制氧糖剥夺复氧BV-2细胞的炎症反应。综上,沉默Vav1可通过抑制小胶质细胞和NLRP3炎症小体的激活减轻脑缺血再灌注后的炎症反应和神经元凋亡。

https://orcid.org/0000-0002-7486-1992 (Huisheng Chen)

关键词: Vav1, 小胶质细胞, NLRP3炎症小体, 脑缺血再灌注, 细胞凋亡, 神经保护, 大脑中动脉闭塞, 炎症因子, 氧糖剥夺复氧, 小胶质细胞活化

Abstract: Microglia, which are the resident macrophages of the central nervous system, are an important part of the inflammatory response that occurs after cerebral ischemia. Vav guanine nucleotide exchange factor 1 (Vav1) is a guanine nucleotide exchange factor that is related to microglial activation. However, how Vav1 participates in the inflammatory response after cerebral ischemia/reperfusion injury remains unclear. In this study, we subjected rats to occlusion and reperfusion of the middle cerebral artery and subjected the BV-2 microglia cell line to oxygen-glucose deprivation/reoxygenation to mimic cerebral ischemia/reperfusion in vivo and in vitro, respectively. We found that Vav1 levels were increased in the brain tissue of rats subjected to occlusion and reperfusion of the middle cerebral artery and in BV-2 cells subjected to oxygen-glucose deprivation/reoxygenation. Silencing Vav1 reduced the cerebral infarct volume and brain water content, inhibited neuronal loss and apoptosis in the ischemic penumbra, and improved neurological function in rats subjected to occlusion and reperfusion of the middle cerebral artery. Further analysis showed that Vav1 was almost exclusively localized to microglia and that Vav1 downregulation inhibited microglial activation and the NOD-like receptor pyrin 3 (NLRP3) inflammasome in the ischemic penumbra, as well as the expression of inflammatory factors. In addition, Vav1 knockdown decreased the inflammatory response exhibited by BV-2 cells after oxygen-glucose deprivation/reoxygenation. Taken together, these findings show that silencing Vav1 attenuates inflammation and neuronal apoptosis in rats subjected to cerebral ischemia/reperfusion through inhibiting the activation of microglia and NLRP3 inflammasome.

Key words: apoptosis, cerebral ischemia/reperfusion, inflammatory cytokines, microglia, microglial activation, middle cerebral artery occlusion, neuroprotection, NLRP3 inflammasome, oxygen-glucose deprivation/reoxygenation, Vav1